Texas High Court Overturns Vioxx Award



DOCUMENTS
  • Opinion


AUSTIN, Texas - The Texas Supreme Court has overturned a $7.75 million Vioxx award, ruling that the plaintiff did not present sufficiently reliable evidence that the painkiller caused a Texas man's heart attack. Merck & Co. v. Garza, No. 09-0073 (Texas Sup. Ct.).

In an Aug. 26 opinion authored by Justice Nathan L. Hecht, the panel ruled that plaintiffs' evidence did not meet the causation requirements set forth in Merrell Dow Pharmaceuticals Inc. v. Havner (953 S.W.2d 706 [Tex. 1997]).

Felicia Garza sued Merck following her husband's April 2001 heart attack, which she blamed on Vioxx prescribed by his cardiologist …






UPCOMING CONFERENCES




HarrisMartin's New Jersey Asbestos Litigation Conference

February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS



HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

January 10, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS